The tweet was deleted by the author.
But we saved everything 🙂.
Nautilus Biotechnology has rolled out the Nautilus Voyager Platform, a major step for the company in recent months.
In addition to the platform launch, Nautilus Biotechnology has initiated its Iterative Mapping Early Access Program and named its first customers. These developments signal a period of rapid growth and activity as the company advances its ambition to transform proteomics research. Details about the new offerings were shared in a company blog post.
Nautilus Biotechnology recently appointed Amber Faust as Vice President of Sales to support commercial growth in proteomics, according to a company announcement. The company also featured US HUPO President-Elect Olga Vitek in a recent episode focused on statistics in proteomics. These moves precede the current launch of the Voyager Platform and the Early Access Program.